|
1
|
Pakzad R, Mohammadian-Hafshejani A,
Khosravi B, Soltani S, Pakzad I, Mohammadian M, Salehiniya H and
Momenimovahed Z: The incidence and mortality of esophageal cancer
and their relationship to development in Asia. Ann Transl Med.
4:292016.PubMed/NCBI
|
|
2
|
Bandla S, Pennathur A, Luketich JD, Beer
DG, Lin L, Bass AJ, Godfrey TE and Litle VR: Comparative genomics
of esophageal adenocarcinoma and squamous cell carcinoma. Ann of
Thorac Surg. 93:1101–1106. 2012. View Article : Google Scholar
|
|
3
|
Zhang HZ, Jin GF and Shen HB:
Epidemiologic differences in esophageal cancer between Asian and
Western populations. Chin J Cancer. 31:281–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Crane SJ, Locke GR III, Harmsen WS,
Zinsmeister AR, Romero Y and Talley NJ: Survival trends in patients
with gastric and esophageal adenocarcinomas: A population-based
study. Mayo Clin Proc. 83:1087–1094. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fan Z, Chang Y, Cui C, Sun L, Wang DH, Pan
Z and Zhang M: Near infrared fluorescent peptide nanoparticles for
enhancing esophageal cancer therapeutic efficacy. Nat Commun.
9:26052018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu Y, Zhang B and Yan B: Enabling
anticancer therapeutics by nanoparticle carriers: The delivery of
Paclitaxel. Int J Mol Sci. 12:4395–4413. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wen H, Jung H and Li X: Drug delivery
approaches in addressing clinical pharmacology-related issues:
Opportunities and challenges. Aaps J. 17:1327–1340. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Greish K: Enhanced permeability and
retention (EPR) effect for anticancer nanomedicine drug targeting.
Methods Mol Biol. 624:25–37. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patra JK, Das G, Fraceto LF, Campos EVR,
Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R,
Swamy MK, Sharma S, et al: Nano based drug delivery systems: Recent
developments and future prospects. J Nanobiotechnology. 16:712018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mo R and Gu Z: Tumor microenvironment and
intracellular signal-activated nanomaterials for anticancer drug
delivery. Mater Today. 19:274–283. 2016. View Article : Google Scholar
|
|
11
|
Zhang X, Ren X, Tang J, Wang J, Zhang X,
He P, Yao C, Bian W and Sun L: Hyaluronic acid reduction-sensitive
polymeric micelles achieving co-delivery of tumor-targeting
paclitaxel/apatinib effectively reverse cancer multidrug
resistance. Drug Deliv. 27:825–835. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mo R, Jiang T, DiSanto R, Tai W and Gu Z:
ATP-triggered anticancer drug delivery. Nat Commun. 5:33642014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan Y, Shi YS, Wu XD, Liang HY, Gao YB, Li
SJ, Zhang XM, Wang F and Gao TM: DNA aptamers that target human
glioblastoma multiforme cells overexpressing epidermal growth
factor receptor variant III in vitro. Acta Pharmacol Sin.
34:1491–1498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huizenga DE and Szostak JW: A DNA aptamer
that binds adenosine and ATP. Biochemistry. 34:656–665. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Modh H, Witt M, Urmann K, Lavrentieva A,
Segal E, Scheper T and Walter JG: Aptamer-based detection of
adenosine triphosphate via qPCR. Talanta. 172:199–205. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Heilkenbrinker A, Reinemann C, Stoltenburg
R, Walte JG, Jochums A, Stahl F, Zimmermann S, Strehlitz B and
Scheper T: Identification of the target binding site of
ethanolamine-binding aptamers and its exploitation for ethanolamine
detection. Anal Chem. 87:677–685. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Canzoneri JC and Oyelere AK: Interaction
of anthracyclines with iron responsive element mRNAs. Nucleic Acids
Res. 36:6825–6834. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takeda K, Uchiyama K, Kinukawa M, Tagami
T, Kaneda M and Watanabe S: Evaluation of sperm DNA damage in bulls
by TUNEL assay as a parameter of semen quality. J Reprod Dev.
61:185–190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo JR, Chen QQ, Lam CW and Zhang W:
Effects of karanjin on cell cycle arrest and apoptosis in human
A549, HepG2 and HL-60 cancer cells. Biol Res. 48:402015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dizaj SM, Jafari S and Khosroushahi AY: A
sight on the current nanoparticle-based gene delivery vectors.
Nanoscale Res Lett. 9:2522014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang L, Lin X, Wang J, Hu Z, Ji Y, Hou S,
Zhao Y, Wu X and Chen C: Novel insights into combating cancer
chemotherapy resistance using a plasmonic nanocarrier: Enhancing
drug sensitiveness and accumulation simultaneously with localized
mild photothermal stimulus of femtosecond pulsed laser. Adv Funct
Mater. 24:4229–4239. 2014. View Article : Google Scholar
|
|
22
|
Blanco E, Shen H and Ferrari M: Principles
of nanoparticle design for overcoming biological barriers to drug
delivery. Nat Biotechnol. 33:941–951. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Akinc A, Thomas M, Klibanov AM and Langer
R: Exploring polyethylenimine-mediated DNA transfection and the
proton sponge hypothesis. J Gene Med. 7:657–663. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Xu CF, Iqbal S, Yang XZ and Wang J:
Responsive nanocarriers as an emerging platform for cascaded
delivery of Nucleic acids to cancer. Adv Drug Deliv Rev.
115:98–114. 2017. View Article : Google Scholar : PubMed/NCBI
|
